Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Orchestra BioMed Holdings (OBIO) Depreciation & Amortization - Total: 2023-2024

Historic Depreciation & Amortization - Total for Orchestra BioMed Holdings (OBIO) over the last 2 years, with Dec 2024 value amounting to $308,000.

  • Orchestra BioMed Holdings' Depreciation & Amortization - Total rose 6.58% to $81,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $329,000, marking a year-over-year change of. This contributed to the annual value of $308,000 for FY2024, which is 7.32% up from last year.
  • As of FY2024, Orchestra BioMed Holdings' Depreciation & Amortization - Total stood at $308,000, which was up 7.32% from $287,000 recorded in FY2023.
  • In the past 5 years, Orchestra BioMed Holdings' Depreciation & Amortization - Total ranged from a high of $308,000 in FY2024 and a low of $287,000 during FY2023.
  • For the 2-year period, Orchestra BioMed Holdings' Depreciation & Amortization - Total averaged around $297,500, with its median value being $297,500 (2023).
  • Data for Orchestra BioMed Holdings' Depreciation & Amortization - Total shows a peak YoY increased of 7.32% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Orchestra BioMed Holdings' Depreciation & Amortization - Total stood at $287,000 in 2023, then grew by 7.32% to $308,000 in 2024.